BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction

Not Applicable

Completed

• Conditions: Waist Circumferential Reduction; Circumferential Reduction
• Interventions: Device: BTL-9000 HFT; Device: sham BTL-9000 HFT

• Registration Number: NCT02023398
• Lead Sponsor: BTL Industries Ltd.

Brief Summary

Prospective, two-arm, randomized study of the effectiveness of the BTL-9000 HFT in achieving 3 cm or greater average waist circumferential reduction in HFT group of subjects relative to the base line and 1 cm or greater reduction relative to the average waist circumferential reduction of the Placebo group.

Detailed Description

Prospective, randomized, blinded, two-arms study of waist circumferential reduction following 5 once-a-week treatments. One arm is the HFT group of 64 subjects who are treated with the BTL-9000 HFT and the other arm is the Placebo group of 38 subjects treated with the sham device. The objective of the study is to demonstrate the effectiveness of the BTL-9000 HFT treatment in achieving average post-treatment waist circumference reduction of 3 cm or greater across the waistline relative to the baseline assessment and of 1 cm or greater than the average waist circumferential reduction of the Placebo group.

Study Timeline

• Study Start: 2013-09
• Primary Completion: 2013-12
• Study Completion: 2013-12
• Study First Submitted: 2013-12-20
• Study First Submitted QC: 2013-12-26
• Study First Posted: 2013-12-30
• Status Verified: 2014-09
• Last Update Submitted: 2014-09-17
• Last Update Posted: 2014-09-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

• Subjects 18-70 years of age of both gender with excess adipose tissue in the abdomen area
• Body Mass Index (BMI) of 25 to 35 kg/m2.
• Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation.
• Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation.

Exclusion Criteria

• • Diabetics dependent on insulin or oral hypoglycemic medications
• Known cardiovascular disease such as arrhythmias, congestive heart failure
• Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.
• Implanted electronic device such as a cardiac pacemaker, bladder stimulator, spinal cord stimulator or electrodes for a myoelectric prosthesis, etc.
• Prior surgical interventions for body sculpting of abdomen such as liposuction
• Medical, physical or other contraindications for body sculpting/ weight loss
• Current use of medication known to affect weight levels and/or cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent
• Any medical condition known to affect weight levels and/or to cause bloating or swelling
• Active infection, wound or other external trauma to the area to be treated
• Pregnant, breast feeding, or planning pregnant before the end of the study
• Serious mental health illness
• Negative affection to heat
• Active or recurrent cancer or current chemotherapy and/or radiation treatment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
HFT group	BTL-9000 HFT	Subjects in the High Frequency Therapy (HFT) group will be treated with the BTL-9000 HFT
Placebo group	sham BTL-9000 HFT	Subjects in the Placebo group with be treated with the sham BTL-9000 HFT

Primary Outcome Measures

Name	Time	Method
Waist Circumference Reduction	1 month follow up after 5 once-a-week treatments	The subjects in the HFT group whose average post-treatment waist circumference shows reduction of 3 cm or greater across the waistline relative to the base line assessment and their mean waist circumferential reduction is 1 cm or greater than the average circumferential reduction of Placebo group are considered to meet the study primary outcome success criteria.

Secondary Outcome Measures

Name	Time	Method
Adverse Events	1 month follow up	Absence of adverse events (AE) associated with the treatment procedure. Safety evaluations of skin reaction in the treatment area would be conducted at every treatment and follow up visits

Trial Locations

Locations (1)

Polyklinika Mytna; 🇸🇰 Bratislava, Slovakia